Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation

Archives of Internal Medicine

Volumn 166, Issue 15, 2006, Pages 1571-1577

  Oncken, Cheryl ^a   Gonzales, David ^b   Nides, Mitchell ^c   Rennard, Stephen ^d   Watsky, Eric ^e   Billing, Clare B ^e   Anziano, Richard ^e   Reeves, Karen ^e  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Los Angeles Clinical Trials   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICOTINIC AGENT; NICOTINIC RECEPTOR PARTIAL AGONIST; PLACEBO; UNCLASSIFIED DRUG; VARENICLINE;

ABNORMAL DREAMING; ADULT; AGED; ARTICLE; ASEPTIC MENINGITIS; CHOLELITHIASIS; CHOLESTEATOMA; CLINICAL TRIAL; COLON CANCER; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DUODENUM ULCER; DYSPEPSIA; ELECTROCARDIOGRAM; FLATULENCE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; HUMAN EXPERIMENT; INSOMNIA; LABORATORY TEST; LONG TERM CARE; MULTIPLE SCLEROSIS; NAUSEA; NEUROLOGIC DISEASE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SIDE EFFECT; SMOKING CESSATION; SOMNOLENCE; SUICIDE ATTEMPT; SYNCOPE; TASTE ACUITY; TREATMENT WITHDRAWAL; UNSTABLE ANGINA PECTORIS; VITAL SIGN; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; BENZAZEPINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; QUINOXALINES; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 33747154992     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.15.1571     Document Type: Article

References (16)

1. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003;362:847-852.
2. Fiore MC. Treating tobacco use and dependence: an introduction to the US Public Health Service Clinical Practice Guideline. Respir Care. 2000;45:1196-1199.
3. World Health Organization. Tobacco or health: a global status report. http://www .cdc.gov/tobacco/WHO. Accessed June 5, 2006.
4. US Surgeon General. The 2004 United States Surgeon General's Report: the health consequences of smoking. N S W Public Health Bull. 2004;15:107.
5. Coe JW, Brooks PR, Vetelino MG, et al. Varenicline: an α4β2 nicotinic receptor partial agonist for smoking cessation. J Med Chem. 2005;48:3474-3477.
6. Faessel HM, Smith BJ, Gibbs MA, Gobey JS, Clark DJ, Burstein AH. Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers. J Clin Pharmacol. In press.
7. Heatherton TF, Koslowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionaire. Br J Addict. 1991;86:1119-1127.
8. National Cancer Institute, National Institutes of Health. Clearing the Air: How to Quit Smoking and Quit for Keeps. Bethesda, Md: National Institutes of Health; 1993.
9. Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG. Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale. Curr Med Res Opin. 2005;21:749-760.
10. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43:289-294.
11. Rose JE, Behm FM, Westman EC. Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy. Exp Clin Psychopharmacol. 1998;6:331-343.
12. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. six-month results from two multicenter controlled clinical trials. JAMA. 1991;266:3133-3138.
13. Abelin T, Ehrsam R, Bühler-Reichert A, et al. Effectiveness of a transdermal nicotine system in smoking cessation studies. Methods Find Exp Clin Pharmacol. 1989;11:205-214.
14. Foulds J, Stapleton J, Hayward M, et al. Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital: a placebo-controlled trial. Arch Fam Med. 1993;2:417-423.
15. Tashkin D, Kanner R, Bailey W, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet. 2001;357:1571-1575.
16. Wagena EJ, Knipschild PG, Huibers MJH, Wouters EF, van Schayck CP. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Arch Intern Med. 2005;165:2286-2292.